
ALT This flowchart outlines the process of a study with sections labeled Enrolment, Allocation, Follow-Up, and Analysis. It shows the number of participants assessed, excluded, and randomized into two groups: Intervention (n=54) and Control (n=51). Details include reasons for participant exclusion and dropout rates throughout the study phases.

ALT Flowchart for managing IBD fatigue. 1. **Fatigue Screening Measures**: Includes IBD-F Self-Assessment Scale and FACIT-Fatigue assessment, categorizing fatigue levels (No fatigue to Severe). 2. **Exclude Other Causes of Fatigue**: Lists diseases, deficiencies, medication side effects, and lifestyle factors. 3. **Patient-led Measures**: Suggests avoiding alcohol, caffeine, and heavy meals. Recommends a balanced diet and regular exercise. 4. **Sleep Difficulties Present?**: - Focus on sleep routine and exercise. - Morning wake time consistency. 5. **Consider Altering Medication**: Guidance on adjusting treatments, checking for partial or effective remission. 6. **Assess Response After 2-3 Months**: Follow-up recommendations, treatment reviews, and measured outcomes. Includes detailed boxes with quantitative scores and criteria within each category.

ALT The image is an informational chart about medications used in treating inflammatory bowel disease (IBD). It is divided into two sections: "Immune Checkpoint Inhibitors (ICI)" and "Targeted therapies." The ICI section includes anti-PD1/PDL-1 medications such as nivolumab and pembrolizumab, and anti-CTLA-4 medication like ipilimumab. The targeted therapies section lists anti-CD20 drugs like rituximab, and BRAF and MEK inhibitors including dabrafenib and trametinib. Each listing describes the medication's effects, common complications, and their association with IBD.






























